Coverage
10 companies
- Lead links
- 5
- Instruments
- Equity / unspecified
- Sourced relationships
- 10
- Distinct source URLs
- 28
- Crawl status
- Research snapshot
Sourced investor record
GV
Public portfolio and funding relationship evidence.
Portfolio links105 lead relationships
- Indexing state
- Evidence-qualified
- Latest dated link
- 2026-05-01
- Earliest dated link
- 2021-02-01
- Snapshot
- 2026-08-25
Official source
Source queued
No official portfolio URL retained in this snapshot.
Evidence ledger
10 retained relationships
A link records a disclosed or retained research relationship; it does not imply a current holding. Every row exposes the source layer, observation date, match method and publication state. Exact dated matches link onward to the funding record.
Observed roles
Evidence threshold
This page meets the retained indexing threshold through an official portfolio URL, three or more linked companies or two distinct relationship-source URLs.
10 relationships shown
| Company | Role | Round | Date | Named sources | Match / state |
|---|---|---|---|---|---|
| Lawhive | participant | Series B | 2026-02-05 | Fortune ↗ · Law ↗ · Wsgr ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Synthesia | lead | Series E | 2026-01-26 | Cnbc ↗ · Synthesia ↗ · Synthesia ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| nPlan | participant | Series B | 2025-10-17 | Nplan ↗ · Info ↗ · Startupmag ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Attio | lead | Series B | 2025-08-26 | PR Newswire ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Metaview | lead | Series B | 2025-06-01 | Metaview ↗ · Unleash ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Isomorphic Labs | participant | First external round (some outlets later referred to a follow-on as 'Series B'), Series B | 2026-05-01 | Isomorphiclabs ↗ · TechCrunch ↗ · Fiercebiotech ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| OMass Therapeutics | lead | Series B | 2023-05-01 | UKTN ↗ · Thebusinessmagazine ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Multiverse | participant | Series D | 2022-06-08 | TechCrunch ↗ · Sifted ↗ · Multiverse ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Ultromics | participant | Series B | 2021-08-16 | PR Newswire ↗ · Finsmes ↗ · Crunchbase ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
| Nothing | lead | Series A | 2021-02-01 | Tech ↗ | reviewed canonical company and investor alias resolutionsource-linked · published |
Recent linked companies
10 of 10 observed companies
The most recently dated retained relationships are shown first; the complete sourced set remains in the ledger above.